Both in Pharmaceuticals
Zevra Therapeutics vs Design Therapeutics
Over the past year ZVRA returned −1.1% and DSGN returned +55.0%; their daily moves had a correlation of 0.15.
ZVRA −1.1% DSGN +55.0%Growth of $1, one year, split-adjusted
| Metric | ZVRA | DSGN |
|---|---|---|
| Price | $10.10 | $10.15 |
| Market cap | $599.8M | $635.2M |
| Today | −1.75% | −4.96% |
| 1 month | +1.1% | −17.7% |
| 6 months | +0.5% | −22.9% |
| Year to date | +12.7% | +8.2% |
| 1 year | −0.4% | +55.4% |
| Revenue growth (YoY) | +53.3% | — |
| Gross margin | 96.2% | — |
| Net margin | 21.2% | — |
| P/E (TTM) | 10.4× | — |
| Price / sales | 4.4× | — |
| Net cash | $221.6M | $207.4M |
| Dividend yield | — | — |
| Volatility (60d) | 44.1% | 55.4% |
| Short % of float | 10.8% | 21.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).